|Articles|November 14, 2016

Rare & Fatal Brain Disorder Confirmed in Patient at Maine Medical Center

Author(s)Kristi Rosa

Creutzfeldt-Jakob disease, a rare & fatal degenerative brain disorder, has been confirmed in a patient at Maine Medical Center.

On Friday, November 11, Maine Medical Center—dubbed as the number one Medical Center in Maine by US News and World Report for 2016-2017—confirmed that a patient at the hospital has been diagnosed with an incredibly rare brain disorder: Creutzfeldt-Jakob disease (CJD).

According to the Centers for Disease Control and Prevention (CDC), CJD is a neurodegenerative disorder that is rapidly progressive. Also known as the human prion disease, CJD is not only rare, but fatal, with patients dying within one year after infection.

The CDC reports that in about 85% of CJD cases there is no recognizable pattern when it comes to transmission of the disease. In addition, according to the hospital’s official news release, CJD transmission within a hospital setting has not occurred in over 20 years.

When it comes to this particular case, healthcare officials suspected CJD after they received initial biopsy results that came in earlier in the week last week. It wasn’t until Friday, however, that their suspicions were confirmed by the National Prion Disease Pathology Surveillance Center at Case Western University.

After receiving confirmation of the fatal disease, the hospital put all of their efforts into prevention and infection control. One of the preventive steps that they took was to reschedule 150 surgeries so that the hospital could focus on decontamination efforts. The team made sure that their efforts were in accordance with safety guidelines that had been released by the CDC pertaining to the disease. Leaving nothing to chance, the team did not just rely on the tracking of surgical equipment, but took the extra step to ensure that any tools that had the potential for being infected were taken care of.

Joel Botler, MD, chief medical officer at MMC commented, “We thought it important to go above and beyond to assure the safety of our patients. Now that we know this case is confirmed, we can see that our response was 100 percent appropriate and that patients should feel confident in the safety of their care at Maine Medical Center.”

In addition to decontamination efforts, healthcare officials are also making a list of patients who had received treatment before the pathology report had been received and depending on the type of procedure performed and the surgical tools that were used, patients thought to be at any risk will be contacted by the hospital.

In the press release, Dr. Botler said, “We are in the process of reaching out to the small number of patients who we think should be notified based on the details of their specific case. Our staff members have been fielding calls from patients who have legitimate concerns and questions about their care. Let me be clear, only a small number of patients who have had surgery at MMC have been exposed to any degree of risk, and that risk is exceedingly low approaching zero.”

Over 100 staff members participated in the decontamination efforts, and, in order to continue performing necessary emergency surgeries, other hospitals in Maine joined the effort by lending necessary equipment to Maine Medical Center in their time of need.

Feature Picture Source: InAweofGod’sCreation​ / flickr / Creative Commons.


Related to this article

Ebola and the Ongoing Tale of US Failures
In mid-May, as the world was still grappling with an unexpected hantavirus outbreak aboard a tourism vessel, news broke of an Ebola outbreak in the Ituri Province of the Democratic Republic of the Congo spanning at least 3 health zones, including Bunia, Rwampara, and Mongbwalu.
This Week's Top 5 Infectious Disease News Stories: September 12-September 18, 2026
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
Measles Update: September 18, 2026
The latest CDC numbers show a 5.37% increase of measles cases from week-to-week. In Pennsylvania, the fourth measles-related death was reported in 2026. Additionally, the CDC has made a change in the way it will report deaths.
CDC Responds to Surge in Rabies Exposures
A "Clinician Outreach" from the Centers for Disease Control and Prevention (CDC) in April anticipated an increase in rabies exposures, and the striking surge in case reports this summer prompted a recent health advisory alert from the federal agency.
New Diagnositics for Legionella Pneumonia May Streamline Care Continuum
Reported cases of Legionnaires’ disease have been on the rise for the past decade, and identifying Legionella bacteria requires specialized testing in the microbiology lab. Here is a clinical overview of Legionella bacteria, including required testing, treatment, and reporting to public health officials.
Ceftriaxone Safety: Separating Signal From Risk
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.